USANA Health Sciences, Inc. - 10-K Summary (Fiscal Year Ended Jan 1, 2011)
Business Context and Reporting Period
This filing covers the fiscal year ended January 1, 2011. USANA Health Sciences, Inc. is a Utah-based corporation that develops, manufactures, and distributes science-based nutritional and personal care products through a global network marketing system. The company operates in 15 markets worldwide, categorized into North America and Asia Pacific regions. A significant development during the period was the indirect acquisition of BabyCare, Ltd., a direct selling company in China, in August 2010, marking USANA's entry into the Chinese market.
Key Financial Metrics
| Metric | 2010 (Actual) | 2009 (Prior Year) |
|---|---|---|
| Net Sales | $517.6 million | $436.9 million |
| Gross Profit | $422.2 million (81.6% margin) | $347.1 million (79.4% margin) |
| Net Earnings | $45.7 million | $33.6 million |
| Diluted EPS | $2.86 | $2.17 |
| Operating Cash Flow | $66.1 million | $32.5 million |
| Associate Incentives | $233.2 million (45.0% of sales) | $196.4 million (44.9% of sales) |
| Cash and Equivalents | $24.2 million | $13.7 million |
| Debt | $0 (Line of credit paid in full) | $7.0 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 18.5% to $517.6 million, driven primarily by a 39.7% increase in Asia Pacific sales (largely due to the BabyCare acquisition and growth in Hong Kong) and favorable currency exchange rates ($21.0 million benefit).
- Profitability: Net earnings rose 36.0% to $45.7 million, aided by improved gross margins (up 220 basis points) and a lower effective tax rate, partially offset by higher operating expenses.
- Customer Base: Active Associates grew 14.6% to 228,000, while Active Preferred Customers grew 14.9% to 77,000. Growth was concentrated in Greater China (up 93.8% for Associates), while North America saw a decline of 11.3% in Associates due to difficult economic conditions.
- Acquisition Impact: The BabyCare acquisition contributed $7.4 million in net sales but reduced net earnings by approximately $3.1 million due to acquisition costs and integration expenses.
Guidance, Outlook, and Risks
Outlook and Strategy: Management plans to focus heavily on integrating BabyCare and expanding operations in China in 2011. They anticipate a potential decline in Hong Kong sales as Associates shift focus to the mainland China market. In North America, the company is launching new training tools and brand recognition initiatives to counter economic headwinds.
Risks and Contingencies:
- China Regulatory Risk: Operations in China are subject to strict government scrutiny. BabyCare currently holds a direct selling license only for Beijing; expansion to other provinces requires additional approvals. Failure to comply with Chinese laws could result in fines or business suspension.
- Associate Dependency: The business relies entirely on independent Associates. High turnover or failure to attract new distributors could materially harm results.
- Currency Fluctuation: With 70.9% of sales generated outside the U.S., earnings are sensitive to exchange rate movements. A strengthening U.S. dollar negatively impacts reported sales.
- Regulatory Compliance: The company faces ongoing scrutiny from the FTC and FDA regarding product claims and network marketing practices.
Investor Verification Checklist
- Verify the timeline and success of BabyCare obtaining direct selling licenses in Chinese provinces beyond Beijing.
- Monitor the trend of active Associates in North America to assess the effectiveness of new retention initiatives.
- Review the impact of currency exchange rates on future quarterly earnings, given the high exposure to foreign markets.
- Track the integration costs and revenue contribution of BabyCare in subsequent quarters to ensure the acquisition accretes to earnings.
- Confirm the status of the $40 million line of credit renewal, which matures in May 2011.